ArticleFrontiers in endocrinology2025
Metabolites mediate the effects of healthy lifestyles on the risks of common age-related diseases.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Socioeconomic stratification in the association between tea consumption and skeletal muscle mass among oilfield workers.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited research is available on the associations between healthy lifestyles and age-related diseases, particularly those involving multiple diseases and their underlying mechanisms. We aimed to determine whether healthy lifestyles are associated with a lower likelihood of age-related diseases, and whether metabolites mediate these associations. Methods: The UK Biobank data cohort was used in this study. Five lifestyle factors (diet, physical activity, sedentary behavior, sleep duration, and alcohol consumption) were combined to determine that composite lifestyle scores. Lifestyle-related metabolic signatures were analyzed using Cox proportional hazards models. We then conducted sequential analyses combining Cox regression, linear regression, extreme gradient boosting (XGBoost), and Shapley additive explanation (SHAP) values to identify metabolites associated with age-related diseases and healthy lifestyle scores. Mediation analysis was performed to investigate the potential mediating effects of the identified metabolites on age-related diseases. Results: Healthy lifestyle scores contributed the most to prevention of chronic obstructive pulmonary disease (COPD) (hazard ratio [HR] [95% confidence interval (CI): 0.72 (0.71, 0.74)], followed by emphysema [HR (95% CI): 0.75 (0.71, 0.78)]. Furthermore, intermediate or healthy lifestyles significantly decreased the age-related risk of stroke, chronic liver disease, chronic kidney disease (CKD), osteoporosis, osteoarthritis, and hypertension. Age-related diseases were associated with the top 10 metabolites, and these associations were individually or jointly mediated. For example, glycoprotein acetylation contributed 14.43% to the overall association between healthy lifestyle scores and inflammatory bowel disease (IBD), whereas low-density lipoprotein (LDL) cholesterol level attenuated this association by 2.92%, the fatty acid content based on the degree of unsaturation showed a 21.64% contribution to the association between the healthy lifestyle score and type 2 diabetes, whereas cholesterol esters in large high-density lipoproteins (HDLs) accounted for 4.57%. Sensitivity analyses verified the robustness and validity of these findings. Conclusions: These findings provide a deeper understanding of the intricate relationships among lifestyle and metabolites and the development of age-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.